Table 1

Demographic, clinical and procedural characteristics

SAVRTAVI
WhiteAsiansP valueWhiteAsiansP value
N4215636220
Age (mean ± SD)71 ± 1066 ± 9<0.000183±780 ± 60.034
Male279 (66%)41 (73%)0.36217 (60%)10 (50%)0.48
BMI (mean ± SD)30 ± 527 ± 40.00228 ± 627 ± 40.30
Comorbidities
Previous MI46 (11%)5 (9%)0.8263 (17%)6 (30%)0.23
DM99 (24%)30 (54%)<0.0001102 (28%)12 (60%)0.005
Smoker273 (65%)22 (39%)0.0004233 (64%)7 (35%)0.015
Hypertension364 (87%)50 (89%)0.68Information not available
Renal impairment244 (58%)40 (71%)0.06Information not available
Pulmonary disease51 (12%)8 (14%)0.67100 (28%)7 (35%)0.45
Stroke/TIA30 (7%)10 (18%)0.01774 (20%)0 (0%)0.034
CAD139 (33%)24 (43%)0.18117 (32%)12 (60%)0.016
LVEF<50%89 (21%)17 (30%)0.1391 (25%)5 (25%)1
EuroSCORE II (%)3.2 ± 4.03.2 ± 2.70.37
 Katz Index of ADL5.4 ± 0.74.8 ± 0.70.0002
 CSHA CFS0.90
 Very fit1 (0.3%)
 Well42 (12%)1 (5%)
 Well—with treated comorbidities166 (46%)9 (45%)
 Vulnerable63 (17%)4 (20%)
 Mildly frail65 (18%)5 (25%)
 Moderately frail25 (6.9%)1 (5%)
Procedure related
AVR±CABG119 (28%)23 (41%)0.061
Urgency
Elective280 (67%)38 (68%)0.88328 (91%)16 (80%)0.13
Urgent139 (33%)18 (32%)1.034 (10%)4 (20%)0.13
Emergency1 (0.2%)0 (0%)1.00 (0%)0 (0%)
Bicuspid AV28 (7%)4 (7%)0.78Information not available
  • Values are mean ± SD or n (%)

  • ADL, activities of daily living; AV, aortic valve; AVR, aortic valve replacement; BMI, body mass index; CABG, coronary artery bypass grafting; CAD, coronary artery disease; CSHA CFS, Canadian Study of Health and Ageing Clinical Frailty Scale; DM, diabetes mellitus; EuroSCORE, European System for Cardiac Operative Risk Evaluation; LVEF, left ventricular ejection fraction; MI, myocardial infarction; SAVR, surgical aortic valve replacement; TAVI, transcatheter aortic valve implantation; TIA, transient ischaemic attack.